Maximus (NYSE:MMS) Reaches New 52-Week Low – What’s Next?

Shares of Maximus, Inc. (NYSE:MMS) hit a new 52-week low during trading on Friday . The company traded as low as $64.66 and last traded at $64.9950, with a volume of 47252 shares traded. The stock had previously closed at $66.03.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on MMS shares. Zacks Research upgraded shares of Maximus from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, December 30th. Weiss Ratings downgraded Maximus from a “buy (b)” rating to a “hold (c+)” rating in a research report on Tuesday, February 24th. Finally, Wall Street Zen lowered Maximus from a “buy” rating to a “hold” rating in a report on Monday, February 23rd. One analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, Maximus presently has an average rating of “Buy”.

Maximus Stock Down 1.5%

The firm has a market cap of $3.55 billion, a P/E ratio of 9.90 and a beta of 0.59. The firm’s fifty day moving average is $79.22 and its 200 day moving average is $84.30. The company has a debt-to-equity ratio of 0.88, a quick ratio of 2.34 and a current ratio of 2.34.

Maximus (NYSE:MMS) last issued its quarterly earnings data on Thursday, February 5th. The health services provider reported $1.85 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.84 by $0.01. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.37 billion. During the same period last year, the business posted $1.61 earnings per share. The business’s revenue for the quarter was down 4.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. As a group, equities research analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 2nd. Stockholders of record on Friday, February 13th were issued a dividend of $0.33 per share. This is an increase from Maximus’s previous quarterly dividend of $0.30. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date of this dividend was Friday, February 13th. Maximus’s payout ratio is 20.09%.

Insider Activity

In other Maximus news, CFO David Mutryn purchased 1,000 shares of the firm’s stock in a transaction that occurred on Monday, February 9th. The shares were acquired at an average cost of $75.62 per share, for a total transaction of $75,620.00. Following the completion of the purchase, the chief financial officer owned 40,037 shares of the company’s stock, valued at approximately $3,027,597.94. The trade was a 2.56% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jan Madsen sold 742 shares of Maximus stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $72.25, for a total transaction of $53,609.50. Following the completion of the sale, the director owned 20,795 shares of the company’s stock, valued at $1,502,438.75. This trade represents a 3.45% decrease in their position. The SEC filing for this sale provides additional information. 1.80% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Maximus

A number of hedge funds have recently added to or reduced their stakes in the stock. Farther Finance Advisors LLC raised its holdings in Maximus by 69.0% in the 4th quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock valued at $25,000 after acquiring an additional 116 shares in the last quarter. Richardson Financial Services Inc. grew its holdings in shares of Maximus by 123.1% during the 3rd quarter. Richardson Financial Services Inc. now owns 348 shares of the health services provider’s stock worth $32,000 after purchasing an additional 192 shares in the last quarter. Advisory Services Network LLC bought a new position in shares of Maximus in the third quarter worth $32,000. Canada Pension Plan Investment Board bought a new position in shares of Maximus in the second quarter worth $35,000. Finally, Cullen Frost Bankers Inc. acquired a new position in Maximus in the third quarter valued at about $38,000. Institutional investors own 97.21% of the company’s stock.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.